留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

弥散张量成像技术在卒中后抑郁疾病中的应用进展

原亚利,  刘勇,  李选,  姚娓,  宫晓洋,  高玉玲

downloadPDF
文章导航 > 分子影像学杂志  > 2021 >  44(6): 1029-1033
原亚利, 刘勇, 李选, 姚娓, 宫晓洋, 高玉玲. 弥散张量成像技术在卒中后抑郁疾病中的应用进展[J]. 分子影像学杂志, 2021, 44(6): 1029-1033. doi: 10.12122/j.issn.1674-4500.2021.06.29
引用本文: 原亚利, 刘勇, 李选, 姚娓, 宫晓洋, 高玉玲. 弥散张量成像技术在卒中后抑郁疾病中的应用进展[J]. 分子影像学杂志, 2021, 44(6): 1029-1033. doi: 10.12122/j.issn.1674-4500.2021.06.29
shu
YUAN Yali, LIU Yong, LI Xuan, YAO Wei, GONG Xiaoyang, GAO Yuling. Application progress of diffusion tensor imaging in post-stroke depression[J]. Journal of Molecular Imaging, 2021, 44(6): 1029-1033. doi: 10.12122/j.issn.1674-4500.2021.06.29
Citation: YUAN Yali, LIU Yong, LI Xuan, YAO Wei, GONG Xiaoyang, GAO Yuling. Application progress of diffusion tensor imaging in post-stroke depression[J]. Journal of Molecular Imaging, 2021, 44(6): 1029-1033. doi: 10.12122/j.issn.1674-4500.2021.06.29
shu

弥散张量成像技术在卒中后抑郁疾病中的应用进展

doi: 10.12122/j.issn.1674-4500.2021.06.29
  • 1.

    大连医科大学附属第一医院康复医学科，辽宁 大连 116011

  • 2.

    大连医科大学附属第二医院中医科，辽宁 大连 116023

基金项目: 

全国中医药创新骨干人才 国中医药人教函[2019]128号

辽宁省自然科学基金 2021-MS-282

辽宁省教育厅科研项目 LJKZ1367

辽宁省中医优秀人才项目 辽卫办发[2021]29号

大连市科技创新智库项目 DLKX2021B03

详细信息
    作者简介:

    原亚利，在读硕士研究生，E-mail: 1547669005@qq.com

    通讯作者:

    刘勇，博士，主任医师，E-mail: fuwa52008@126.com

Application progress of diffusion tensor imaging in post-stroke depression

  • 1.

    Department of Rehabilitation Medicine, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China

  • 2.

    Department of Traditional Chinese Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China

    摘要
  • 摘要: 脑卒中是严重危害人民群众生命安全的疾病，位居我国致残率和致死率病因的首位，卒中后抑郁（PSD）是脑卒中后最为常见的大脑功能失调状态，其加剧卒中后的认知功能障碍，延缓卒中后的康复进程，增加卒中的致残率、病死率与复发率。弥散张量成像技术可以显示活体脑白质结构，被广泛应用于脑疾病的发病机制研究，并逐渐成为疗效评价的指标。本文综述了弥散张量成像技术在卒中后抑郁疾病中的应用情况，主要从卒中后抑郁的危险因素、发病机制假说、生物标记物方面进行概括分析，并阐述了基于弥散张量成像研究的卒中后抑郁的风险因素，旨在探讨其研究现状与应用进展。

     

    Abstract: Stroke is a serious disease endangering people's life and safety, ranking first in the cause of disability and mortality in China. Post-stroke depression is the most common brain dysfunction after stroke, which aggravates the cognitive dysfunction after stroke, delays the rehabilitation process after stroke, and increases the disability, mortality and recurrence rate of stroke. Diffusion tensor imaging, which can display the structure of white matter in vivo, has been widely used in the study of the pathogenesis of brain diseases, and has gradually become an indicator of curative effect evaluation. This paper reviews the application of diffusion tensor imaging in post-stroke depression, in order to explore its research status and application progress.

     

    • HTML全文
    • 参考文献(44)
  • [1] Towfighi A, Ovbiagele B, El Husseini N, et al. Poststroke depression: a scientific statement for healthcare professionals from the American heart association/American stroke association[J]. Stroke, 2017, 48(2): e30-43. http://stroke.ahajournals.org/content/48/2/e30.full.pdf
    [2] Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405. doi: 10.1016/S1474-4422(18)30500-3
    [3] Cai W, Mueller C, Li YJ, et al. Post stroke depression and risk of stroke recurrence and mortality: a systematic review and metaanalysis [J]. Ageing Res Rev, 2019, 50: 102-9. doi: 10.1016/j.arr.2019.01.013
    [4] 王少石, 周新雨, 朱春燕. 卒中后抑郁临床实践的中国专家共识[J]. 中国卒中杂志, 2016, 11(8): 685-93. doi: 10.3969/j.issn.1673-5765.2016.08.015
    [5] Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review[J]. J Mol Neurosci, 2008, 34(1): 51-61. doi: 10.1007/s12031-007-0029-0
    [6] Sagnier S, Catheline G, Dilharreguy B, et al. Normal- appearing white matter integrity is a predictor of outcome after ischemic stroke [J]. Stroke, 2020, 51(2): 449-56. doi: 10.1161/STROKEAHA.119.026886
    [7] Yang S, Hua P, Shang X, et al. A significant risk factor for poststroke depression: the depression-related subnetwork[J]. J Psychiatry Neurosci, 2015, 40(4): 259-68. doi: 10.1503/jpn.140086
    [8] Zhao Z, Zhang W, Zhang Y, et al. Multimodal magnetic resonance imaging and therapeutic intervention with yi-Nao-Jie-yu decoction in a rat model of post-stroke depression[J]. Front Psychiatry, 2020, 11: 557423. doi: 10.3389/fpsyt.2020.557423
    [9] 许孝南, 吴军, 陈旭辉, 等. 卒中后抑郁的扩散张量成像研究进展[J]. 中国脑血管病杂志, 2015, 12(6): 321-4. doi: 10.3969/j.issn.1672-5921.2015.06.010
    [10] Das J, G K R. Post stroke depression: The sequelae of cerebral stroke [J]. Neurosci Biobehav Rev, 2018, 90: 104-14. doi: 10.1016/j.neubiorev.2018.04.005
    [11] Ibeneme SC, Nwosu A, Anyachukwu CC, et al. Burden and factors associated with post-stroke depression in East central Nigeria[J]. Afr Health Sci, 2017, 17(3): 859-67. doi: 10.4314/ahs.v17i3.29
    [12] Babkair LA. Risk factors for poststroke depression: an integrative review[J]. J Neurosci Nurs, 2017, 49(2): 73-84. doi: 10.1097/JNN.0000000000000271
    [13] Zhang Y, Zhao H, Fang Y, et al. The association between lesion location, sex and poststroke depression: Meta-analysis[J]. Brain Behav, 2017, 7(10): e00788.
    [14] Karakus K, Kunt R, Memis CO, et al. The factors related to earlyonset depression after first stroke[J]. Psychogeriatrics, 2017, 17(6): 414-22. doi: 10.1111/psyg.12266
    [15] Karaahmet OZ, Gurcay E, Avluk OC, et al. Poststroke depression: risk factors and potential effects on functional recovery[J]. Int J Rehabilitation Res, 2017, 40(1): 71-5. doi: 10.1097/MRR.0000000000000210
    [16] Wang L, Xu H, Ren W, et al. Low serum prealbumin levels in poststroke depression[J]. Psychiatry Res, 2016, 246: 149-53. doi: 10.1016/j.psychres.2016.09.021
    [17] Douven E, Staals J, Freeze WM, et al. Imaging markers associated with the development of post-stroke depression and apathy: Results of the cognition and affect after stroke-a prospective evaluation of risks study[J]. Eur Stroke J, 2020, 5(1): 78-84. doi: 10.1177/2396987319883445
    [18] Robinson RG, Jorge RE. Post-stroke depression: a review[J]. Am J Psychiatry, 2016, 173(3): 221-31. doi: 10.1176/appi.ajp.2015.15030363
    [19] De Ryck A, Fransen E, Brouns R, et al. Poststroke depression and its multifactorial nature: results from a prospective longitudinal study [J]. J Neurol Sci, 2014, 347(1/2): 159-66. http://smartsearch.nstl.gov.cn/paper_detail.html?id=e3cb1c63ec13723638bc4a823f72fd51
    [20] Feng C, Fang M, Liu XY. The neurobiological pathogenesis of poststroke depression[J]. Scientific World Journal, 2014, 2014: 521349.
    [21] Villa RF, Ferrari F, Moretti A. Post-stroke depression: Mechanisms and pharmacological treatment [J]. Pharmacol Ther, 2018, 184: 131- 44. doi: 10.1016/j.pharmthera.2017.11.005
    [22] Li W, Ling S, Yang Y, et al. Systematic hypothesis for post-stroke depression caused inflammation and neurotransmission and resultant on possible treatments[J]. Neuro Endocrinol Lett, 2014, 35 (2): 104-9. http://pdfs.semanticscholar.org/d6aa/8a2dc8ee4127afc8c9bf081b86df51622ba6.pdf
    [23] Loubinoux I, Kronenberg G, Endres M, et al. Post-stroke depression: mechanisms, translation and therapy[J]. J Cell Mol Med, 2012, 16 (9): 1961-9. doi: 10.1111/j.1582-4934.2012.01555.x
    [24] Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression [J]. Mol Psychiatry, 2013, 18(9): 963-74. http://www.nature.com/articles/mp201320.pdf
    [25] Noonan K, Carey LM, Crewther SG. Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke [J]. J Stroke Cerebrovasc Dis, 2013, 22(7): e124-35. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.008
    [26] Spalletta G, Bossù P, Ciaramella A, et al. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines [J]. Mol Psychiatry, 2006, 11(11): 984-91. doi: 10.1038/sj.mp.4001879
    [27] Zhang L, Sui RB, Zhang L, et al. Morphological and metabolic alteration of cerebellum in patients with post-stroke depression[J]. Cell Physiol Biochem, 2016, 40(3-4): 420-30. doi: 10.1159/000452557
    [28] Zhang XF, Zou W, Yang Y. Effects of IL-6 and cortisol fluctuations in post-stroke depression[J]. J Huazhong Univ Sci Technolog Med Sci, 2016, 36(5): 732-5. doi: 10.1007/s11596-016-1653-0
    [29] 姚恩生, 唐燕, 王伟. 激光散斑成像技术监测抑郁症样小鼠脑血流动力学改变的初步研究[J]. 石河子大学学报: 自然科学版, 2020, 38 (6): 761-6. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZN202006017.htm
    [30] Ding X, Liu R, Li W, et al. A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD) [J]. Metab Brain Dis, 2016, 31(2): 279-87. doi: 10.1007/s11011-015-9748-z
    [31] Wang M, Gui X, Wu L, et al. Amino acid metabolism, lipid metabolism, and oxidative stress are associated with post-stroke depression: a metabonomics study[J]. BMC Neurol, 2020, 20(1): 250. doi: 10.1186/s12883-020-01780-7
    [32] Luo L, Li C, Du X, et al. Effect of aerobic exercise on BDNF/ proBDNF expression in the ischemic Hippocampus and depression recovery of rats after stroke[J]. Behav Brain Res, 2019, 362: 323-31. doi: 10.1016/j.bbr.2018.11.037
    [33] Zhang Y, Jiang H, Yue Y, et al. The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder[J]. Sci Rep, 2017, 7(1): 8674. doi: 10.1038/s41598-017-09000-y
    [34] Pietra Pedroso VS, Rachid MA, Teixeira AL. Biomarkers in poststroke depression[J]. Curr Neurovasc Res, 2016, 13(2): 163-73. doi: 10.2174/1567202613666160219120114
    [35] Douven E, Köhler S, Rodriguez MMF, et al. Imaging markers of poststroke depression and apathy: a systematic review and meta-analysis [J]. Neuropsychol Rev, 2017, 27(3): 202-19. doi: 10.1007/s11065-017-9356-2
    [36] Carey LM, Crewther S, Salvado O, et al. STroke imAging pRevention and treatment (START): a longitudinal stroke cohort study: Clinical trials protocol [J]. Int J Stroke, 2015, 10(4): 636-44. doi: 10.1111/ijs.12190
    [37] Yasuno F, Taguchi A, de Yamamoto A, et al. Microstructural abnormalities in white matter and their effect on depressive symptoms after stroke[J]. Psychiatry Res: Neuroimaging, 2014, 223 (1): 9-14. doi: 10.1016/j.pscychresns.2014.04.009
    [38] Pasi M, Poggesi A, Salvadori E, et al. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-tuscany study[J]. Int J Geriatr Psychiatry, 2016, 31(6): 611-8. doi: 10.1002/gps.4368
    [39] Haque ME, Gabr RE, Hasan KM, et al. Ongoing secondary degeneration of the limbic system in patients with ischemic stroke: a longitudinal MRI study[J]. Front Neurol, 2019, 10: 154. doi: 10.3389/fneur.2019.00154
    [40] Ye CF, Wu J, Chen XH, et al. Structural changes of cingulate cortex in post stroke depression[C]//2016 38th annual international conference of the IEEE engineering in medicine and biology society (EMBC). Orlando, FL, USA. IEEE, 2016: 1099-102.
    [41] Xu X, Tang R, Zhang L, et al. Altered topology of the structural brain network in patients with post-stroke depression[J]. Front Neurosci, 2019, 13: 776. doi: 10.3389/fnins.2019.00776
    [42] 叶辰飞, 吴军, 陈旭辉, 等. 磁共振影像技术在卒中后抑郁疾病的研究进展[J]. 中国医学物理学杂志, 2016, 33(10): 1038-46. doi: 10.3969/j.issn.1005-202X.2016.10.013
    [43] 李木子, 隋汝波, 张霏霏, 等. 卒中后抑郁患者小脑弥散张量改变的临床研究[J]. 中风与神经疾病杂志, 2016, 33(5): 397-401. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFSJ201605004.htm
    [44] Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images[J]. NMR Biomed, 1995, 8(7/8): 333-44. http://www.researchgate.net/profile/Peter_Basser2/publication/14463796_Inferring_Microstructural_Features_and_the_Physiological_State_of_Tissues_from_Diffusion-Weighted_Images/links/561d01cd08ae50795afd6fed.pdf
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  159
  • HTML全文浏览量:  120
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-29
  • 网络出版日期:  2022-01-05
  • 刊出日期:  2021-11-20

目录

    /

    返回文章
    返回
    • 版权所有© 2013《分子影像学杂志》编辑部 ICP备00000000号
    • 重点提示: Adobe Reader6可能造成全文显示不正常，请升级为Adobe Reader7或更高。
    • 地址: 广东省广州市广州大道北1838号 Tel: 020-61648176 E-mail: 

    本系统由 北京仁和汇智信息技术有限公司 开发  技术支持：info@rhhz.net

    x 关闭 永久关闭

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者：

    为了缩短出版时滞，促进科研成果的快速传播，我刊自2024年1月起，刊期由双月刊变更为月刊。本刊主要栏目有：基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱！

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日